Therapeutic Areas: Oncology

Choose Therapeutic Area
Infectious diseases incl. Covid-19
Rare diseases
20 years of conducting high quality oncology research

Cromos Pharma has vast expertise in designing and executing scientifically rigorous clinical trials in oncology that adhere to the most stringent regulatory requirements. This includes developing study protocols, identifying appropriate endpoints, selecting target patient populations, and assisting sponsors in determining appropriate dosing and treatment schedules. 

We are experts in rapid patient recruitment

One of the biggest challenges in oncology clinical trials is finding and enrolling patients who meet specific study criteria. Cromos Pharma has extensive networks of clinical sites and investigators, and we use targeted recruitment strategies to find eligible patients and increase enrollment rates. 

We have a deep understanding of global and regional regulatory requirements for cancer clinical trials and work closely with regulatory agencies to ensure compliance. This includes submitting regulatory documents, managing safety reporting, and ensuring that clinical trials meet ethical and safety standards. Cromos Pharma has experienced project managers who oversee all aspects of clinical trials, ensuring that projects are completed on time and within budget. We use proprietary project management and risk assessment tools to track progress and identify potential issues before they arise.

Cromos Pharma provides first-rate medical writing services to help sponsors prepare regulatory documents, such as  clinical trial protocols, investigator brochures and clinical study reports. We also excel at preparing manuscripts for publication in scientific journals.

By offering a wide range of services that streamline the clinical trial process, Cromos Pharma helps bring new cancer treatments to patients faster and more efficiently.

Our oncology experience includes:
    • Advanced Solid Tumors
    • Cervical Cancer
    • Chemo Induced Anorexia, Cachexia
    • Colorectal Cancer
    • Endometrial Cancer
    • Febrile Neutropenia
    • Liver Cancer
    • Melanoma
    • Myelodysplastic Syndrome
    • Non-Hodgkin Lymphoma
    • Non-Small Cell Lung Cancer
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Renal Cell Carcinoma
    • Small-Cell Lung Cancer
    • Stomach Cancer

Rare Cancers:

    • Acute Myeloid Leukemia (AML)
    • B-Cell Non-Hodgkin Lymphoma
    • Cutaneous T-Cell Lymphoma
    • Gastrointestinal Stromal Tumor (GIST)
    • Glioblastoma Multiforme (GBM)
    • Hepatocellular Carcinoma
    • Myelodysplastic Syndrome with Myelofibrosis
    • Osteosarcoma
    • Triple-Negative Breast Cancer
Cromos Pharma Oncology experience in the last five years
Clinical Sites
our Success story
A Phase III trial in Metastatic Castration-Resistant Prostate Cancer
Click to openclose
Why Cromos Pharma
  • We are the only CRO to offer “No Patients, No Payment” risk sharing program, where the sponsor pays only if we deliver on our milestones.
  • We have the scientific and clinical expertise to support your clinical studies, from early to late phase, from single- to multi-country execution strategies.
  • By leveraging our international expertise, we deliver unparalleled results through diligent feasibility analysis, rapid startup, and accelerated recruitment, while utilizing proactive risk management strategies and maintaining the highest data quality.
  • Our team has vast expertise in organizing scientific advisory board meetings of key opinion leaders, clinicians, and industry stakeholders.



more therapeutics